title: [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
abstract: A 62-year-old man had undergone anterior resection of rectum for rectosigmoid colon cancer with liver metastases. Postoperatively, the FOLOFOX6 regimen was performed in three courses. Metastatic liver tumors showed progressive disease(PD) on CT scan. The treatment was then changed to the FOLFIRI regimen for three courses. Metastatic liver tumors showed a partial response(PR)on CT scan. After six courses of the FOLFIRI regimen, the patient was given seven courses of the FOLFIRI +BV regimen. Hepatic resection of S2, S3, S4 and S6 segment was performed. The histological effect of chemotherapy was complete response(CR).
authors.affiliation: Dept. of Surgery, JA Hiroshima General Hospital.
authors.forename: Aki
authors.initials: A
authors.lastname: Kuwada
authors.forename: Atsushi
authors.initials: A
authors.lastname: Nakamitsu
authors.forename: Yuji
authors.initials: Y
authors.lastname: Imamura
authors.forename: Mohei
authors.initials: M
authors.lastname: Kouyama
authors.forename: Shinnosuke
authors.initials: S
authors.lastname: Uekami
authors.forename: Kunio
authors.initials: K
authors.lastname: Touge
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Taogoshi
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Fukuda
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Daimaru
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin